Bart Vanderborght

Journal Article
A1
open access

Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis

Kevin De Muynck (UGent) , Lander Heyerick (UGent) , Federico Francesco De Ponti (UGent) , Bart Vanderborght (UGent) , Tim Meese, Sanne Van Campenhout, Leen Baudonck, Eva Gijbels, Pedro M. Rodrigues, Jesus M. Banales, et al.

(2024) HEPATOLOGY. 79(2). p.269-288

Add to list

Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma

Bart Vanderborght (UGent) , Kevin De Muynck (UGent) , Eva Gijbels, Sander Lefere (UGent) , Charlotte Scott (UGent) , Martin Guilliams (UGent) , Alain Beschin, Mathieu Vinken, Xavier Verhelst (UGent) , Anja Geerts (UGent) , et al.

(2023) INTERNATIONAL JOURNAL OF CANCER. 152(12). p.2615-2628

Add to list

Journal Article
A1
open access

Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease

Eva Gijbels, Kevin De Muynck (UGent) , Bart Vanderborght (UGent) , Tim Meese, Filip Van Nieuwerburgh (UGent) , Aude Vanlander, Frederik Berrevoet (UGent) , Bart Hendrikx (UGent) , Anne Hoorens (UGent) , Hans Van Vlierberghe (UGent) , et al.

(2023) GENES & DISEASES. 10(1). p.18-21

Add to list

Journal Article
A1
open access

Kupffer cells contested as early drivers in the pathogenesis of primary sclerosing cholangitis

Kevin De Muynck (UGent) , Bart Vanderborght (UGent) , Federico Francesco De Ponti (UGent) , Eva Gijbels, Sophie Van Welden (UGent) , Martin Guilliams (UGent) , Charlotte Scott (UGent) , Alain Beschin, Mathieu Vinken, Sander Lefere (UGent) , et al.

(2023) AMERICAN JOURNAL OF PATHOLOGY. 193(4). p.366-379

Add to list

PhD Thesis
open access

Targeting angiogenic and inflammatory components of the tumor microenvironment in hepatocellular carcinoma

Bart Vanderborght (UGent)

(2022)

Add to list

Journal Article
A1
open access

Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

Martin Guilliams (UGent) , Johnny Bonnardel (UGent) , Birthe Haest (UGent) , Bart Vanderborght (UGent) , Camille Wagner (UGent) , Anneleen Remmerie, Anna Bujko (UGent) , Liesbet Martens (UGent) , Tinne Thoné (UGent) , Robin Browaeys (UGent) , et al.

(2022) CELL. 185(2). p.379-396

Add to list

Journal Article
A2
open access

Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models

Helena Degroote (UGent) , Sander Lefere (UGent) , Astrid Vandierendonck, Bart Vanderborght (UGent) , Tim Meese, Filip Van Nieuwerburgh (UGent) , Xavier Verhelst (UGent) , Anja Geerts (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2021) ONCOTARGET. 12(6). p.562-577

Add to list

Journal Article
A1
open access

The gut–liver axis in chronic liver disease : a macrophage perspective

Kevin De Muynck (UGent) , Bart Vanderborght (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2021) CELLS. 10(11).

Add to list

Journal Article
A1
open access

In vivo and in vitro models of hepatocellular carcinoma : current strategies for translational modeling

Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght (UGent) , Tereza Cristina da Silva, Luís Fernando Barbisan, Wellington Andraus, Lindsey Devisscher (UGent) , Niels Olsen Saraiva Câmara, et al.

(2021) CANCERS. 13(21).

Add to list

Journal Article
A1
open access

NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma

Aster Vandierendonck (UGent) , Helena Degroote (UGent) , Bart Vanderborght (UGent) , Xavier Verhelst (UGent) , Anja Geerts (UGent) , Lindsey Devisscher (UGent) and Hans Van Vlierberghe (UGent)

(2021) JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 40(1).

Academic Bibliography

Bart Vanderborght

Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis

Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte-derived cells does not alter the induction or progression of hepatocellular carcinoma

Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease

Kupffer cells contested as early drivers in the pathogenesis of primary sclerosing cholangitis

Targeting angiogenic and inflammatory components of the tumor microenvironment in hepatocellular carcinoma

Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models

The gut–liver axis in chronic liver disease : a macrophage perspective

In vivo and in vitro models of hepatocellular carcinoma : current strategies for translational modeling

NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma

Contents

Support

Contact